Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

PET [11C]DASB imaging of serotonin transporters in patients with alcoholism.

Brown AK, George DT, Fujita M, Liow JS, Ichise M, Hibbeln J, Ghose S, Sangare J, Hommer D, Innis RB.

Alcohol Clin Exp Res. 2007 Jan;31(1):28-32.

PMID:
17207098
2.

Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907.

Rylands AJ, Hinz R, Jones M, Holmes SE, Feldmann M, Brown G, McMahon AW, Talbot PS.

Biol Psychiatry. 2012 Dec 15;72(12):1004-11. doi: 10.1016/j.biopsych.2012.06.024. Epub 2012 Jul 25.

PMID:
22835812
4.

Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.

Matsumoto R, Ichise M, Ito H, Ando T, Takahashi H, Ikoma Y, Kosaka J, Arakawa R, Fujimura Y, Ota M, Takano A, Fukui K, Nakayama K, Suhara T.

Neuroimage. 2010 Jan 1;49(1):121-6. doi: 10.1016/j.neuroimage.2009.07.069. Epub 2009 Aug 4.

PMID:
19660554
5.

Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.

Frankle WG, Narendran R, Huang Y, Hwang DR, Lombardo I, Cangiano C, Gil R, Laruelle M, Abi-Dargham A.

Biol Psychiatry. 2005 Jun 15;57(12):1510-6.

PMID:
15953487
6.

Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET.

Kim JH, Son YD, Kim JH, Choi EJ, Lee SY, Lee JE, Cho ZH, Kim YB.

Psychiatry Res. 2015 Jan 30;231(1):50-7. doi: 10.1016/j.pscychresns.2014.10.022. Epub 2014 Nov 5.

PMID:
25465315
7.

In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.

Walker M, Ehrlichmann W, Stahlschmidt A, Pichler BJ, Fischer K.

J Nucl Med. 2016 Jan;57(1):115-21. doi: 10.2967/jnumed.115.163683. Epub 2015 Oct 29.

8.

Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans.

Parsey RV, Ojha A, Ogden RT, Erlandsson K, Kumar D, Landgrebe M, Van Heertum R, Mann JJ.

J Nucl Med. 2006 Nov;47(11):1796-802.

9.

Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependence.

Martinez D, Slifstein M, Gil R, Hwang DR, Huang Y, Perez A, Frankle WG, Laruelle M, Krystal J, Abi-Dargham A.

Biol Psychiatry. 2009 Jan 15;65(2):175-80. doi: 10.1016/j.biopsych.2008.08.034. Epub 2008 Oct 29.

10.

Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease.

Ouchi Y, Yoshikawa E, Futatsubashi M, Yagi S, Ueki T, Nakamura K.

J Nucl Med. 2009 Aug;50(8):1260-6. doi: 10.2967/jnumed.109.063008. Epub 2009 Jul 17.

11.

Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods.

Frankle WG, Slifstein M, Gunn RN, Huang Y, Hwang DR, Darr EA, Narendran R, Abi-Dargham A, Laruelle M.

J Nucl Med. 2006 May;47(5):815-26.

12.

Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB.

van de Giessen E, Rosell DR, Thompson JL, Xu X, Girgis RR, Ehrlich Y, Slifstein M, Abi-Dargham A, Siever LJ.

J Psychiatr Res. 2014 Nov;58:147-54. doi: 10.1016/j.jpsychires.2014.07.025. Epub 2014 Aug 6.

PMID:
25145808
13.

Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.

Boileau I, Warsh JJ, Guttman M, Saint-Cyr JA, McCluskey T, Rusjan P, Houle S, Wilson AA, Meyer JH, Kish SJ.

Mov Disord. 2008 Sep 15;23(12):1776-80. doi: 10.1002/mds.22212.

PMID:
18661545
14.

Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?

Buchert R, Thiele F, Thomasius R, Wilke F, Petersen K, Brenner W, Mester J, Spies L, Clausen M.

J Psychopharmacol. 2007 Aug;21(6):628-34. Epub 2006 Nov 8.

PMID:
17092972
15.

The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.

Zhu Z, Guo N, Narendran R, Erritzoe D, Ekelund J, Hwang DR, Bae SA, Laruelle M, Huang Y.

Nucl Med Biol. 2004 Nov;31(8):983-94.

PMID:
15607480
16.

Quantifying serotonin transporters by PET with [11C]-DASB before and after interferon-α treatment.

Shapiro PA, Sloan RP, Deochand C, Franceschi AM, Delorenzo C, Mann JJ, Parsey RV.

Synapse. 2014 Nov;68(11):548-55. doi: 10.1002/syn.21766. Epub 2014 Aug 4.

17.
18.

Altered serotonin transporter availability in patients with multiple sclerosis.

Hesse S, Moeller F, Petroff D, Lobsien D, Luthardt J, Regenthal R, Becker GA, Patt M, Thomae E, Seese A, Meyer PM, Bergh FT, Sabri O.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):827-35. doi: 10.1007/s00259-013-2636-z. Epub 2014 Feb 22. Erratum in: Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1640-1.

PMID:
24562640
19.

In vivo quantification of serotonin transporters using [(11)C]DASB and positron emission tomography in humans: modeling considerations.

Ogden RT, Ojha A, Erlandsson K, Oquendo MA, Mann JJ, Parsey RV.

J Cereb Blood Flow Metab. 2007 Jan;27(1):205-17. Epub 2006 May 17. Erratum in: J Cereb Blood Flow Metab. 2007 Apr;27(4):874.

20.

Supplemental Content

Support Center